GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Panacea Life Sciences Holdings Inc (OTCPK:PLSH) » Definitions » Price-to-Operating-Cash-Flow

PLSH (Panacea Life Sciences Holdings) Price-to-Operating-Cash-Flow : (As of Oct. 31, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Panacea Life Sciences Holdings Price-to-Operating-Cash-Flow?

As of today (2024-10-31), Panacea Life Sciences Holdings's share price is $0.09. Panacea Life Sciences Holdings's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Jun. 2024 was $-0.09. Hence, Panacea Life Sciences Holdings's Price-to-Operating-Cash-Flow Ratio for today is .

The historical rank and industry rank for Panacea Life Sciences Holdings's Price-to-Operating-Cash-Flow or its related term are showing as below:

During the past 4 years, Panacea Life Sciences Holdings's highest Price-to-Operating-Cash-Flow Ratio was 0.03. The lowest was 0.00. And the median was 0.00.

PLSH's Price-to-Operating-Cash-Flow is not ranked *
in the Drug Manufacturers industry.
Industry Median: 17.94
* Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.

Panacea Life Sciences Holdings's Cash Flow from Operations per share for the three months ended in Jun. 2024 was $-0.03. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Jun. 2024 was $-0.09.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 35.90% per year.

During the past 4 years, Panacea Life Sciences Holdings's highest 3-Year average Operating Cash Flow per Share Growth Rate was 35.90% per year. The lowest was 35.90% per year. And the median was 35.90% per year.


Panacea Life Sciences Holdings Price-to-Operating-Cash-Flow Historical Data

The historical data trend for Panacea Life Sciences Holdings's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Panacea Life Sciences Holdings Price-to-Operating-Cash-Flow Chart

Panacea Life Sciences Holdings Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Price-to-Operating-Cash-Flow
- - - -

Panacea Life Sciences Holdings Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Price-to-Operating-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Panacea Life Sciences Holdings's Price-to-Operating-Cash-Flow

For the Drug Manufacturers - Specialty & Generic subindustry, Panacea Life Sciences Holdings's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Panacea Life Sciences Holdings's Price-to-Operating-Cash-Flow Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Panacea Life Sciences Holdings's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Panacea Life Sciences Holdings's Price-to-Operating-Cash-Flow falls into.



Panacea Life Sciences Holdings Price-to-Operating-Cash-Flow Calculation

Panacea Life Sciences Holdings's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio=Share Price/Cash Flow from Operations per share (TTM)
=0.09/-0.092
=

Panacea Life Sciences Holdings's Share Price of today is $0.09.
Panacea Life Sciences Holdings's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.09.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio=Market Cap/Cash Flow from Operations

Panacea Life Sciences Holdings Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Panacea Life Sciences Holdings's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Panacea Life Sciences Holdings Business Description

Traded in Other Exchanges
N/A
Address
5910 S University Boulevard, C18-193, Greenwood Village, CO, USA, 80121
Panacea Life Sciences Holdings Inc is a holding company organized as a plant-based natural health ingredient and product company, specializing in the development, manufacturing, research, and distribution of products and rapidly growing natural health and wellness market segment for both humans and animals. Its products are CBD Softgels, CBD Tablets, CBD Topicals, CBD Skin Care, CBD Tinctures, CBD Edibles, CBD Patches, CBD Pets, and PPE.
Executives
Leslie Buttorff director, 10 percent owner, officer: CHIEF EXECUTIVE OFFICER 16194 W 45TH DRIVE, GOLDEN CO 80403
Janice Nerger director 5910 S UNIVERSITY BLVD., C18-193, GREENWOOD VILLAGE CO 80121
Nathan Joel Berman officer: CONTROLLER & PRIN ACTNG OFCR 16194 W 45TH DRIVE, GOLDEN CO 80403
22nd Century Group, Inc. 10 percent owner 8560 MAIN STREET, SUITE 4, WILLIAMSVILLE NY 14221
Harvey J Kesner 10 percent owner 65 E. 55TH STREET, NEW YORK NY 10022
Lawrence Wert director 170 NUTTALL RD, RIVERSIDE IL 60546
Chesne Derek Du officer: Chief Growth Officer 80 NE 4TH AVENUE, SUITE 28, DELRAY BEACH FL 33483
Alvaro Daniel Alberttis director 80 NE 4TH AVENUE, SUITE 28, DELRAY BEACH FL 33483
Vladislav Yampolsky director, 10 percent owner 332 PLAZA REAL, BOCA RATON FL 33432
Steven A Schwartz director 332 PLAZA REAL, BOCA RATON FL 33432
Andrew L. Johnson officer: Chief Strategy Officer 80 NE 4TH AVE. SUITE 28, DELRAY BEACH FL 33483
Emiliano Angel Aloi officer: President 510 SUNSHINE DRIVE, DELRAY BEACH FL 33444
Jonathan Gilbert director, officer: Executive Chairman 36 SYCAMORE LANE, ROSALYN HEIGHTS NY 11577
John C Price director 4721 IRONTON STREET, BUILDING A, DENVER CO 80239
Kevin James Esval director NEURO HITECH INC, ONE PENN PLAZA STE 1503, NEW YORK NY 10019

Panacea Life Sciences Holdings Headlines

From GuruFocus

Panacea Announces Letter of Intent to Acquire N7 Enterprises, Inc.

By Stock market mentor Stock market mentor 01-23-2023